05-04-2010: Epigenomics AG and Warnex Medical Laboratories, a division of Warnex Inc., announced that they have signed a non-exclusive licensing agreement for Epigenomics' colorectal cancer biomarker Septin9. Under the terms of the agreement, Warnex has obtained the rights to establish a laboratory-developed test for Septin9 and offer colorectal cancer blood testing services in Canada. Warnex plans to launch the testing service in the next few months. As the first laboratory to offer Septin9 testing in Canada, Warnex, subject to certain conditions, enjoys a time-limited head-start period of exclusivity for the Canadian market. Epigenomics will be entitled to certain royalty payments. Further contractual details were not disclosed.
In numerous studies with over 3,300 blood samples, Epigenomics has demonstrated that methylated DNA of the Septin9 gene in blood plasma is a reliable indicator of colorectal cancer of all stages and all locations. This paved the way for a convenient blood test for colorectal cancer early detection that can easily be integrated into the patient's routine physical, is non-invasive and does not require any drug or dietary restrictions.
"Warnex is the ideal partner to make colorectal cancer blood testing based on our Septin9 biomarker available in Canada. This agreement is an important further step in the international rollout of Septin9 testing, which is already commercially available in the US and Europe", commented Geert Nygaard, Chief Executive Officer of Epigenomics.
Contact / Request information
Request further information free of charge:
Epigenomics Biomarker Predicts Drug Resistance in Colorectal Cancer
Epigenomics AG announced the publication of a study authored by Professor Matthias Ebert at University of Heidelberg entitled “TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer” in The New England Journal of Medicine.In this study involving more than 200 patients in four independent coho ... more
Epigenomics AG: Noel Doheny Appointed as New CEO of US-Subsidiary Epigenomics Inc.
Epigenomics AG announced the appointment of Noel Doheny as the new Chief Executive Officer (CEO) of its subsidiary Epigenomics Inc. in Seattle, WA, USA, reporting to Geert Nygaard, CEO of Epigenomics AG. Mr. Doheny will start in his new position in early May 2011. Mr. Doheny has 30+ years o ... more
Epigenomics AG and NextPharma Sign Global Manufacturing Deal for Colorectal Cancer Blood Test
Epigenomics AG and NextPharma Technologies announced that the companies have signed a global manufacturing contract for Epigenomics' Epi proColon product. Epi proColon, currently marketed in Europe, is the world's first in-vitro diagnostic test for the detection of colorectal cancer in a s ... more
Epigenomics AG and Warnex Medical Laboratories, a division of Warnex Inc., announced that they have signed a non-exclusive licensing agreement for Epigenomics' colorectal cancer biomarker Septin9. Under the terms of the agreement, Warnex has obtained the rights to establish a laboratory-dev ... more
Warnex first to launch quantitative PCR test for food testing
Warnex Inc. announced the launch of a quantitative test for Campylobacter for use with the real-time PCR-based Warnex(TM) Rapid Pathogen Detection System. With no enrichment required, this test detects and quantifies Campylobacter in poultry rinses within 3 hours. According to Warnex this ... more
Warnex launches two novel tests for Campylobacter and 24-hour Listeria
Warnex Inc. announced it is launching two new tests for use with the Warnex(TM) Rapid Pathogen Detection System. The first test detects Campylobacter jejuni, C. coli and C. lari in poultry rinses, and the second is a one-step 24-hour test for Listeria species in environmental samples. The d ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
